AI, Machine Learning, and ChatGPT in Hypertension

Anita T Layton,Anita T. LaytonDepartment of Applied Mathematics,Department of Biology,Cheriton School of Computer Science,and School of Pharmacology,University of Waterloo,Ontario,Canada.
DOI: https://doi.org/10.1161/hypertensionaha.124.19468
IF: 9.8968
2024-02-21
Hypertension
Abstract:Hypertension, Ahead of Print. Hypertension, a leading cause of cardiovascular disease and premature death, remains incompletely understood despite extensive research. Indeed, even though numerous drugs are available, achieving adequate blood pressure control remains a challenge, prompting recent interest in artificial intelligence. To promote the use of machine learning in cardiovascular medicine, this review provides a brief introduction to machine learning and reviews its notable applications in hypertension management and research, such as disease diagnosis and prognosis, treatment decisions, and omics data analysis. The challenges and limitations associated with data-driven predictive techniques are also discussed. The goal of this review is to raise awareness and encourage the hypertension research community to consider machine learning as a key component in developing innovative diagnostic and therapeutic tools for hypertension. By integrating traditional cardiovascular risk factors with genomics, socioeconomic, behavioral, and environmental factors, machine learning may aid in the development of precise risk prediction models and personalized treatment approaches for patients with hypertension.
peripheral vascular disease
What problem does this paper attempt to address?